Image: Smiling and playful childImage: Doctor Tom ChauImage: Child playing

Bloorview Research Institute

Scientist Profiles

Doug Biggar

Name: Doug Biggar

Title: Clinician Scientist

Theme: Evaluation of Care

Education:

Queen's University, Faculty of Medicine
Kingston, Ontario - Degree of M.D

Fellow, Royal College of Physicians & Surgeons of Canada

University Position:

Professor of Paediatrics, University of Toronto, Toronto, Ontario

Research Interests:

Impact of long term corticosteroid treatment for boys with Duchenne muscular dystrophy.

Selected Peer-Reviewed Journal Publications:

Biggar, W.D., Gingras, M., Fehlings, D., Harris, V., Steele, C.: Deflazacort Treatment of Duchenne Muscular Dystrophy. J Pediatrics 138 (1), 45-50, 2001.

Silversides, C., Harris, V., Webb, G., Biggar, W.D.: Cardiac Function in patients with Duchenne Muscular Dystrophy: The Benefits of Deflazacort. American J of Cardiology. 91:769-772, 2003.

Alman, B., Raza, N., Biggar, W.D.: Deflazacort Attenuates the Progression of Scoliosis in Duchenne Muscular Dystrophy. J of Bone and Joint Surgery (American edition) 86:519-524, 2004.

Tarnopolsky, M.A., Mahoney, D.J., Vajsar, J., Rodriguez, C., Doherty, T.J., Roy, B.D., Biggar, W.D.: Creatine monohydrate enhances strength and body composition in boys with Duchenne muscular dystrophy. Neurology. 62:1771-1777, 2004.

Biggar, W.D., Politano, L., Harris, V.A., Passamano, L., Vajsar, J., Alman, B., Palladino, A., Comi, L.I. Nigro, G.: Deflazacort Treatment in Duchenne Muscular Dystrophy: A Comparison of Two Different Protocols. Neuromuscular Disorders, Vol. 14, 476-482, 2004.

Hawker, G.A., Ridout R., Harris, V.A., Chase, C., Fielding, L., Biggar, W.D.: Alendronate in the Treatment of Low Bone Mass in Steroid-Treated Boys with Duchenne Muscular Dystrophy. Archives of Physical Medicine and Rehabilitation, Vol. 86, (2):284-288, 2005.

Leitch, K.K., Raza, N., Biggar, W.D., Stephen, D., Wright, J.G., Alman, B.: Should Foot Surgery Be Performed for Children With Duchenne Muscular Dystrophy J Pediatric Orthop. 25(1):95-97, Jan/Feb. 2005.

Biggar, W.D., Bachrach, L.K., Henderson, R.C., Kalkwarf, H., Plotkin, H., Wong, B.L.: Bone health in Duchenne muscular dystrophy. Neuromuscular Disorders, Vol. 15(1):80-85, 2005.

Biggar, W.D., Harris, V.A., Eliasoph, L., Alman, B.: Long-term benefits of delfazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscular Disorders, Vol. 16,249-255, 2006.

Contact Information:
Bloorview Research Institute,
Holland Bloorview Kids Rehabilitation Hospital
150 Kilgour Road
Toronto, Ontario
M4G 1R8

Tel: 416-425-6220, extension 3813
Fax: 416-425-6591

E-mail:  dbiggar at hollandbloorview dot ca *(see Note below)

*Note: Copy the above e-mail address(es) into the To field of your e-mail message and reconstruct the e-mail address(es) by removing the spaces and replacing the “at” and “dot” with the proper symbols (@ and .) respectively.

Back to Scientist Profiles